Monday, August 13, 2018 10:11:13 PM
From their form 1-A
In October 2017, Emerald Health Pharmaceuticals Australia Pty Ltd. (EHP Australia) was created as a wholly-owned subsidiary of Emerald Health
Pharmaceuticals Inc. to facilitate the operation of clinical trials. EHP Australia’s functional currency, the Australian dollar, is also its reporting currency,
and its financial statements are translated to U.S. dollars, the EFP’s reporting currency, prior to consolidation.
In December 2017, Emerald Health Pharmaceuticals, España Sociedad Limidata, (EHP España) was created as its wholly-owned subsidiary. EHP
España’s functional currency, the Euro, is also its reporting currency, and its financial statements are translated to U.S. dollars prior to consolidation.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM